Wildy logo
(020) 7242 5778
enquiries@wildy.com

Wildy’s Book News

Book News cover photo

Vol 22 No 4 April/May 2017

Book of the Month

Cover of Whistleblowing: Law and Practice

Whistleblowing: Law and Practice

Price: £175.00

Pupillage & Student Offers

Special Discounts for Pupils, Newly Called & Students

Read More ...


Secondhand & Out of Print

Browse Secondhand Online

Read More...


UK Public Holiday May 2017

Wildy's will be closed on Monday 29th May and will re-open on Tuesday 30th May.

Online book orders received during the time we are closed will be processed as soon as possible once we re-open on Tuesday.

As usual Credit Cards will not be charged until the order is processed and ready to despatch.

Any non-UK eBook orders placed after 5pm on the Friday 26th May will not be processed until Tuesday 30th May. UK eBook orders will be processed as normal.

Hide this message

Pharmaceutical Medicine, Biotechnology and European Law

Image not available lge

ISBN13: 9780521792493
ISBN: 0521792495
Published: June 2001
Publisher: Cambridge University Press
Country of Publication: UK
Format: Hardback
Price: £80.00



This is a Print On Demand Title.
The publisher will print a copy to fulfill your order. Books can take between 1 to 3 weeks. Looseleaf titles between 1 to 2 weeks.

European law has been faced with increasingly complex issues emerging from rapid developments in pharmaceutical medicine and biotechnology. A team of distinguished European legal practitioners and academics reassess the impact of European law on health care and pharmaceutical law.

The essays are grouped under four themes: Free movement of goods and persons, competition and intellectual property; European drug regulation; Biotechnology; and Product liability and transnational health care litigation. The book reviews the impact of European law on movement of health care professionals and pharmaceuticals, patent and trademark rights, the Product Liability Directive, laws on product liability and intellectual property claims.

It examines recent developments in drug regulation, particularly data protection, abridged applications for marketing authorisations and the European Medicines Evaluation Agency. A compelling analysis is made of the Biotechnology Directive morality clauses. This important study offers a valuable resource for the pharmaceutical and biotechnology industries, legal academics and practitioners alike.

Image not available lge
Subjects:
Medical Law
Contents:
Part I. Free Movement of Goods and Persons, Competition and Intellectual Property:
1. The free movement of goods I: pharmaceuticals, patents and parallel trade Professor W. R. Cornish
2. The free movement of goods II: pharmaceuticals, trade marks and parallel imports Belinda Isaac
3. The free movement of health care professionals in the European Community Julian Lonbay
4. EC competition law, drugs and intellectual property: recent developments Professor Leigh Hancher
Part II. European Drug Regulation:
5. Data protection and abridged applications for marketing authorisations in the pharmaceutical industry Ian Dodds-Smith
6. The role of the European Medicines Evaluation Agency (EMEA) in the harmonisation of pharmaceutical regulation Antoine Cuvillier
Part III. Biotechnology:
7. The morality clauses of the Directive on the Legal Protection of Biotechnological Inventions: conflict, compromise, and the patent community Deryck Beyleveld, Professor Roger Brownsword and Margaret Llewelyn
Part IV. Product Liability and Transnational Health Care Litigation:
8. The development risk defence and the European Court of Justice
increased injury costs and the Supplementary Protection Certificate Richard Goldberg
9. Transnational health care litigation and the Private International Law (Miscellaneous Provisions) Act 1995, Part III Jonathan Harris.